Navigation Links
Mitochondrial cholesterol makes response to chemotherapy difficult in hepatic cancer
Date:7/14/2008

This release is available in Spanish.

Cancer is a disease characterised by important metabolic alterations. Not only these adaptative changes give higher proliferative capacity to cancer cells, but they also contribute to higher resistance to chemotherapeutic agents. The research group led by Dr. Jos Carlos Fernndez-Checa in the Institut d'Investigacions Biomdiques de Barcelona of the CSIC (IIBB-CSIC), a centre linked to the Institut d'Investigacions Biomdiques August Pi i Sunyer (IDIBAPS), is centred in the mitochondrion and its role in programmed cell death or apoptosis. The mitochondrion is the organelle in charge of the cell's respiration and of energy generation to satisfy important metabolic functions, which are altered in cancer. In an article published in Cancer Research (68(13):5246-56) with Joan Montero and Albert Morales as first signatories and Ana Colell as co-director of the study, IIBB-CSIC-IDIBAPS researchers describe how the increase of cholesterol in the mitochondrial membrane plays a key role in the resistance to cytotoxic agents acting via mitochondrion, including doxorubicin, a common drug in chemotherapy. This research has been developed in the framework of the Centre of Network Biomedical Research on Hepatic and Digestive diseases (CIBERehd).

Hepatocarcinoma is the most frequent form of hepatic cancer. It has a high mortality rate due to, among other causes, the lack of an effective treatment and due to its high resistance against the current chemotherapy strategy. In order to improve the quality of treatments, it is important to identify the strategies permitting the cell to avoid chemotherapy's toxicity. The supraphysiological level of mitochondrial cholesterol in hepatocarcinoma and in other cancers is well known, but its role in the mitochondrial regulation of cellular death and resistance to chemotherapy was not known. Cholesterol is an indispensable molecule for the cell membrane, and normally, its endogenous synthesis is closely regulated to prevent the accumulation of cholesterol, precisely what occurs in carcinogenesis.

After the application of several strategies in hepatocarcinoma samples, such as the inhibition of the de novo cholesterol synthesis and its mitochondrial transport, researchers concluded that cholesterol increase in the mitochondrial membrane was responsible for chemotherapy resistance. In collaboration with the University of the Basque Country and the Swiss firm Merk Serono International, a model in liposomes simulating the composition of the mitochondrial membrane was developed in order to check the effects of cholesterol on its fluidity and response to several stimuli. The mitochondrion contains indispensable molecules so that the cell initiates apoptosis, vut it is necessary that pores are formed in the membrane in order to release these molecules into the cell and then initiate cell death mechanisms. This process requires an appropriate fluidity environment to permit permeabilisation of the mitochondrial membrane and the release of the mitochondrial proapoptotic molecules. Results point to mitochondrial cholesterol as the main responsible of the disorders in the mitochondrial membrane fluidity as the factors avoiding a satisfactory response to treatment.


'/>"/>

Contact: lex Argem
aargemi@clinic.ub.es
34-932-275-700
IDIBAPS - Institut d'Investigacions Biomdiques August Pi i Sunyer
Source:Eurekalert

Related biology news :

1. Scientists show that mitochondrial DNA variants are linked to risk factors for type 2 diabetes
2. Zebrafish to shed light on human mitochondrial diseases
3. Mitochondrial dysfunction and redox signaling in atrial tachyarrhythmia
4. Hebrew University develops novel approach for treating mitochondrial disorders
5. Dominant cholesterol-metabolism ideas challenged by new research
6. Research explains link between cholesterol and heart disease
7. Cholesterol metabolism links early- and late-onset Alzheimers disease
8. Corazonas Foods and Brandeis University partner to create cholesterol-reducing snacks
9. MIT links gene to cholesterol
10. More on mate tea: lower cholesterol and an international agreement
11. Contribution of cholesterol transporter to vascular disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2017)... RAM Group , Singaporean based ... in biometric authentication based on a novel  ... to perform biometric authentication. These new sensors are based on ... Ram Group and its partners. This sensor will have ... and security. Ram Group is a next generation ...
(Date:4/19/2017)... , April 19, 2017 The ... vendor landscape is marked by the presence of several ... however held by five major players - 3M Cogent, ... companies accounted for nearly 61% of the global military ... companies in the global military biometrics market boast global ...
(Date:4/17/2017)... , April 17, 2017 NXT-ID, Inc. ... company, announces the filing of its 2016 Annual Report on Form ... Exchange Commission. ... Form 10-K is available in the Investor Relations section of the ... on the SEC,s website at http://www.sec.gov . 2016 ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... At its national ... Dr. Suneel I. Sheikh, the co-founder, CEO and chief research scientist of Minnesota-based ... selected for membership in ARCS Alumni Hall of Fame . ASTER Labs ...
(Date:10/11/2017)... a leading provider of patient support solutions, has announced the ... which will launch this week. The VMS CNEs will address ... enhance the patient care experience by delivering peer-to-peer education programs ... to help women who have been diagnosed and are being ... ...
(Date:10/10/2017)... ... , ... San Diego-based team building and cooking events company, Lajollacooks4u, has unveiled ... bold new look is part of a transformation to increase awareness, appeal to new ... , It will also expand its service offering from its signature gourmet cooking classes ...
(Date:10/10/2017)... Calif. , Oct. 10, 2017 SomaGenics ... from the NIH to develop RealSeq®-SC (Single Cell), expected ... for profiling small RNAs (including microRNAs) from single cells ... Program highlights the need to accelerate development of approaches ... "New techniques for measuring levels ...
Breaking Biology Technology: